FindTrial
Sign In

Randomized controlled clinical study of inhale budesonide and inject methylprednisolone in AECOPD patients

Multicenter randomized controlled clinical study of inhale budesonide suspension and inject methylprednisolone sodium succinate in AECOPD patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002058
Enrollment
Unknown
Registered
2012-03-30
Start date
2012-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

A:inhale budesonide suspension
B:inject methylprednisolone sodium succinate

Sponsors

the 3rd affiliated hospital of Anhui Medical University (The 1st hospital of Hefei)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. COPD patient must be confirmed by spirometer; 2. Patient must be diagnosed as acute exacerbation of COPD by at least qualified;3.Study sequence, and purpose, and procedure must be informed to the patient, and the patient must sign the "Informed Consent" by himself/herself.

Exclusion criteria

Exclusion criteria: 1. Patient condition deteriorating must conduct invasive mechanical ventilation; 2. Less than 1 month after AECOPD or long term use of oral or inject glucocorticoids; 3. Complicated with other heart or brian or kidney or liver disease and must be treated during hospitalization period; 4. Complicated with pneumatothorax or pulmonary thromboembolism or pneumonia or other respiratory diseases.

Design outcomes

Primary

MeasureTime frame
FEV1;PaO2;COPD assessment;—

Countries

China

Contacts

Public ContactLi Xiu
huxikelixiu@yahoo.com.cn+86 13705510633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026